View : 600 Download: 0
Velcade (R), Thalidomide, Dexamethasone (VTD) Followed by Melphalan, Prednisone, Thalidomide (MPT) Maintenance as a First Line Treatment Demonstrates High Response Rates for High-Risk Patients with Multiple Myeloma (MM) Who Are Non-Transplant Candidates: Updated Results of Phase II Trial.
- Title
- Velcade (R), Thalidomide, Dexamethasone (VTD) Followed by Melphalan, Prednisone, Thalidomide (MPT) Maintenance as a First Line Treatment Demonstrates High Response Rates for High-Risk Patients with Multiple Myeloma (MM) Who Are Non-Transplant Candidates: Updated Results of Phase II Trial.
- Authors
- Eom, HyeonSeok; Kim, Yeo-Kyeoung; Chung, Joo-Seop; Kim, Kihyun; Kim, Hyo-Jung; Kim, HoYoung; Jin, Jong-Youl; Do, Young-Rok; Oh, Suk-Joong; Suh, Cheolwon; Seong, Chu-Myong; Kim, Chul Soo; Lee, Dong Soon; Lee, Jae Hoon
- Ewha Authors
- 성주명
- SCOPUS Author ID
- 성주명
- Issue Date
- 2008
- Journal Title
- BLOOD
- ISSN
- 0006-4971
- Citation
- BLOOD vol. 112, no. 11, pp. 962 - 962
- Publisher
- AMER SOC HEMATOLOGY
- Indexed
- SCI; SCIE; SCOPUS
- Document Type
- Meeting Abstract
- Appears in Collections:
- 의과대학 > 의학과 > Journal papers
- Files in This Item:
There are no files associated with this item.
- Export
- RIS (EndNote)
- XLS (Excel)
- XML